# A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment

> **NCT04927052** · NA · COMPLETED · sponsor: **Prollenium Medical Technologies Inc.** · enrollment: 136 (actual)

## Conditions studied

- Volume Deficit in the Mid-face

## Interventions

- **DEVICE:** Revanesse Shape + with Lidocaine
- **DEVICE:** Juvederm Voluma with Lidocaine.

## Key facts

- **NCT ID:** NCT04927052
- **Lead sponsor:** Prollenium Medical Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04927052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04927052, "A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04927052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*